Learn more

RACTIGEN THERAPEUTICS

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    121,269
About

RACTIGEN THERAPEUTICS has a total of 14 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are APTAHEM AB, DITESAN LTD and AAL SCIENT INC.

Patent filings per year

Chart showing RACTIGEN THERAPEUTICSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kang Moorim 13
#2 Li Longcheng 13
#3 Wu Jiancheng 7
#4 Place Robert F 4
#5 Kang Tao 1

Latest patents

Publication Filing date Title
WO2021052470A1 Nucleic acid molecule for treating immune thrombocytopenia and application thereof
WO2021000928A1 Oligomeric nucleic acid molecule activating atoh1 gene and use thereof
WO2020221309A1 Oligomeric nucleic acid molecule, and application thereof in acute intermittent porphyria treatment
WO2020151726A1 Oligonucleotides for skin care
WO2020135677A1 Oligomeric nucleic acid molecule and application thereof
WO2020155534A1 Oligonucleotide molecule and application thereof in tumor therapy
EP3778893A1 Method for activating p21 gene expression
KR20200140377A New small active RNA